BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31425924)

  • 1. RUNX1 deletion/amplification in therapy-related acute myeloid leukemia: A case report and review of the literature.
    Nguyen D; Li Y; Safah H; Brown TC
    Cancer Genet; 2019 Oct; 238():37-43. PubMed ID: 31425924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel case of intrachromosomal amplification and insertion of RUNX1 on derivative chromosome 2 in pediatric AML.
    Jain H; Shetty D; Roy Moulik N; Narula G; Subramanian PG; Banavali S
    Cancer Genet; 2021 Jun; 254-255():65-69. PubMed ID: 33647813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marker chromosomes are a significant mechanism of high-level RUNX1 gene amplification in hematologic malignancies.
    Moosavi SA; Sanchez J; Adeyinka A
    Cancer Genet Cytogenet; 2009 Feb; 189(1):24-8. PubMed ID: 19167608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute multilineage (B/myeloid) leukemia with RUNX1 duplication/amplification and hypereosinophilia.
    Holmes A; Coviello J; Velagaleti G
    Eur J Haematol; 2014 Nov; 93(5):449-52. PubMed ID: 24912843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute myeloid leukemia with del(X)(p21) and cryptic RUNX1/RUNX1T1 from ins(8;21)(q22;q22q22) revealed by atypical FISH signals.
    Jang JH; Yoo EH; Kim HJ; Kim DH; Jung CW; Kim SH
    Ann Clin Lab Sci; 2010; 40(1):80-4. PubMed ID: 20124335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of rare reciprocal RUNX1 rearrangements by next-generation sequencing in acute myeloid leukemia.
    Flach J; Shumilov E; Joncourt R; Porret N; Tchinda J; Legros M; Scarpelli I; Hewer E; Novak U; Schoumans J; Bacher U; Pabst T
    Genes Chromosomes Cancer; 2020 Apr; 59(4):268-274. PubMed ID: 31756777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a new translocation that disrupts the RUNX1 gene in a patient with de novo acute myeloid leukemia.
    Lucena-Araujo AR; de Figueiredo-Pontes LL; de Oliveira FM; de Lourdes Chauffaille M; Falcao RP; Rego EM
    Med Oncol; 2012 Jun; 29(2):1114-8. PubMed ID: 21380778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH.
    Schoch C; Haferlach T; Bursch S; Gerstner D; Schnittger S; Dugas M; Kern W; Löffler H; Hiddemann W
    Genes Chromosomes Cancer; 2002 Sep; 35(1):20-9. PubMed ID: 12203786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of multiplex ligation dependent probe amplification (MLPA) for identification of acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21 (iAMP21) in a Brazilian population.
    Fuka G; Farias-Vieira TM; Hummel L; Blunck CB; Santoro JC; Terra-Granado E; Barbosa TC; Emerenciano M; Pombo-de-Oliveira MS
    Mol Cytogenet; 2015; 8():35. PubMed ID: 26060508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of RUNX1 exons 1 and 2 associated with familial platelet disorder with propensity to acute myeloid leukemia.
    Cavalcante de Andrade Silva M; Krepischi ACV; Kulikowski LD; Zanardo EA; Nardinelli L; Leal AM; Costa SS; Muto NH; Rocha V; Velloso EDRP
    Cancer Genet; 2018 Apr; 222-223():32-37. PubMed ID: 29666006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RUNX1-MTG16 fusion gene in acute myeloblastic leukemia with t(16;21)(q24;q22): case report and review of the literature.
    De Braekeleer E; Douet-Guilbert N; Le Bris MJ; Morel F; Férec C; De Braekeleer M
    Cancer Genet Cytogenet; 2008 Aug; 185(1):47-50. PubMed ID: 18656694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RUNX1 amplification in lineage conversion of childhood B-cell acute lymphoblastic leukemia to acute myelogenous leukemia.
    Podgornik H; Debeljak M; Zontar D; Cernelc P; Prestor VV; Jazbec J
    Cancer Genet Cytogenet; 2007 Oct; 178(1):77-81. PubMed ID: 17889714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel RUNX1-C11orf41 fusion gene in a case of acute myeloid leukemia with a t(11;21)(p14;q22).
    Abe A; Katsumi A; Kobayashi M; Okamoto A; Tokuda M; Kanie T; Yamamoto Y; Naoe T; Emi N
    Cancer Genet; 2012 Nov; 205(11):608-11. PubMed ID: 23102734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of unusual iAMP21 B-lymphoblastic leukemia (iAMP21-ALL) from the Mayo Clinic and Children's Oncology Group.
    Koleilat A; Smadbeck JB; Zepeda-Mendoza CJ; Williamson CM; Pitel BA; Golden CL; Xu X; Greipp PT; Ketterling RP; Hoppman NL; Peterson JF; Harrison CJ; Akkari YMN; Tsuchiya KD; Shago M; Baughn LB
    Genes Chromosomes Cancer; 2022 Dec; 61(12):710-719. PubMed ID: 35771717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is intrachromosomal amplification of chromosome 21 (iAMP21) always intrachromosomal?
    Tsuchiya KD; Davis B; Gardner RA
    Cancer Genet; 2017 Dec; 218-219():10-14. PubMed ID: 29153092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RUNX1 amplification in AML with myelodysplasia-related changes and ring 21 chromosomes.
    Burillo-Sanz S; Vargas MT; Morales-Camacho RM; Caballero-Velázquez T; Sánchez J; García-Lozano JR; Pérez de Soto I; Prats-Martín C; Bernal R; Pérez-Simón JA
    Hematol Oncol; 2017 Dec; 35(4):894-899. PubMed ID: 26947932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IS THE AMPLIFICATION OF c-MYC, MLL AND RUNX1 GENES IN AML AND MDS PATIENTS WITH TRISOMY 8, 11 AND 21 A FACTOR FOR A CLONAL EVOLUTION IN THEIR KARYOTYPE?
    Angelova S; Spassov B; Nikolova V; Christov I; Tzvetkov N; Simeonova M
    Tsitol Genet; 2015; 49(3):25-32. PubMed ID: 26214902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two novel translocations disrupt the RUNX1 gene in acute myeloid leukemia.
    Dai H; Xue Y; Pan J; Wu Y; Wang Y; Shen J; Zhang J
    Cancer Genet Cytogenet; 2007 Sep; 177(2):120-4. PubMed ID: 17854666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gain of chromosome 21 or amplification of chromosome arm 21q is one mechanism for increased ERG expression in acute myeloid leukemia.
    Weber S; Haferlach C; Jeromin S; Nadarajah N; Dicker F; Noël L; Zenger M; Alpermann T; Kern W; Haferlach T; Schnittger S
    Genes Chromosomes Cancer; 2016 Feb; 55(2):148-57. PubMed ID: 26542308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexistence of iAMP21 and
    Gu J; Reynolds A; Fang L; DeGraffenreid C; Sterns K; Patel KP; Medeiros LJ; Lin P; Lu X
    Mol Cytogenet; 2016; 9():84. PubMed ID: 27895713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.